Stockreport

Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases [Yahoo! Finance]

Cullinan Therapeutics, Inc.  (CGEM) 
PDF Clinical observations from CLN-978 B-NHL study show rapid, deep, and sustained B cell depletion and clinical activity Corporate name change to Cullinan Therapeutics r [Read more]